Llwytho...
Promising systemic immunotherapies in head and neck squamous cell carcinoma
Patients with head and neck squamous cell carcinoma (HNSCC) demonstrate poor survival and significant treatment morbidity with standard therapy. The immune profile in HNSCC, whether caused by carcinogen exposure or human papillomavirus (HPV), is notably immunosuppressive. Early clinical trials of im...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Oral Oncol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2013
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861147/ https://ncbi.nlm.nih.gov/pubmed/24126223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2013.09.009 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|